The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or tumor sidedness.
 
Ramya Thota
No Relationships to Disclose
 
Timothy Yeatman
No Relationships to Disclose
 
Nishant Gandhi
Employment - Caris Life Sciences
 
Mingli Yang
No Relationships to Disclose
 
Michael Schell
No Relationships to Disclose
 
Lance Pflieger
No Relationships to Disclose
 
Andrey Loboda
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Michael Nebozhyn
No Relationships to Disclose
 
Andrew Elliott
Employment - Caris Life Sciences
 
Joanne Xiu
Employment - Caris Life Sciences
 
George W. Sledge
Employment - Caris Life Sciences
Leadership - Caris Life Sciences; Syndax; Tessa Therapeutics
Stock and Other Ownership Interests - Caris Life Sciences; Pionyr; Syndax
Consulting or Advisory Role - Caris Life Sciences; Syndax
Travel, Accommodations, Expenses - Caris Life Sciences
 
Moh'd M. Khushman
Stock and Other Ownership Interests - Blueprint Medicines; Cardiff Oncology; Moderna Therapeutics; Regeneron
Speakers' Bureau - Caris Life Sciences
 
Emil Lou
Honoraria - Boston Scientific; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Intima; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
Sanjay Goel
Stock and Other Ownership Interests - Johnson and Johnson; Merck; Moderna Therapeutics
Honoraria - Amgen; Merck
Research Funding - BeiGene (Inst); Deciphera (Inst); Dragonfly Therapeutics (Inst); EMD Serono (Inst); PharmaMar (Inst); Takeda (Inst); TLC PharmaChem (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364
 
Warren Jack Pledger
No Relationships to Disclose